Efficacy of JAK1/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison
Gemma Marinella(Fondazione Stella Maris), Silvia Maria Orsi(Istituto Giannina Gaslini), Rosa Pasquariello(Fondazione Stella Maris), Francesco Nicita(Sapienza University of Rome), Marina Martinez Popple(Istituto Giannina Gaslini), Jessica Galli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Elisabetta Amadori(Istituto Giannina Gaslini), Maria Margherita Mancardi(Istituto Giannina Gaslini), Davide Tonduti, Ylenia Vaia, Duccio Maria Cordelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Daniela Longo(Bambino Gesù Children's Hospital), Roberta Battini(Fondazione Stella Maris), Davide Politano(University of Pavia), Fiammetta Zunica(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alessandro Orsini(University of Pisa), Luca Soliani(Istituto delle Scienze Neurologiche di Bologna), Marco Cattalini(University of Brescia), Mariasavina Severino(United States Military Academy), Antonella Insalaco(Bambino Gesù Children's Hospital), Francesca Felicia Operto(Magna Graecia University), Cecilia Parazzini(Ospedale dei Bambini Vittore Buzzi), Filippo Arrigoni(Ospedale dei Bambini Vittore Buzzi), Anna Fetta(Istituto delle Scienze Neurologiche di Bologna), Stefano Volpi(Istituto Giannina Gaslini), Elisa Fazzi(University of Brescia), Silvia Nicolosi, Anna Pichiecchio(University of Pavia), Lorenzo Pinelli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 2
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441